Intimation of schedule of Analysts/ Investors Earning Call for the Quarter-IV and Financial Year ended on March 31, 2026
ORCHPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Orchid Pharma has announced an earnings call scheduled for May 26, 2026 at 4:30 PM IST to discuss Q4 and full year FY26 results (ending March 31, 2026). The call is hosted by Systematix Institutional Equities. Key management including Managing Director Mr. Manish Dhanuka, Whole Time Director Mr. Mridul Dhanuka, and CFO Mr. Sunil Kumar Gupta will participate. Dial-in details and conference pass registration details are provided for investors. The information will also be available on the company's website.
This is a standard procedural disclosure under SEBI regulations. No direct impact on stock price expected from this announcement alone, but the upcoming earnings call provides an opportunity for investors to hear management's perspective on Q4 and full-year performance.